This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975 Sep;11(9):599-607.

doi: 10.1016/0014-2964(75)90092-4.

R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness

G Atassi, H J Tagnon

PMID: 1220975
DOI: 10.1016/0014-2964(75)90092-4

R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness

G Atassi et al. Eur J Cancer (1965). 1975 Sep.

. 1975 Sep;11(9):599-607.

doi: 10.1016/0014-2964(75)90092-4.

Authors

G Atassi, H J Tagnon

PMID: 1220975
DOI: 10.1016/0014-2964(75)90092-4

No abstract available

PubMed Disclaimer

Similar articles

R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
Atassi G, Schaus C, Tagnon HJ. Atassi G, et al. Eur J Cancer (1965). 1975 Sep;11(9):609-14. doi: 10.1016/0014-2964(75)90093-6. Eur J Cancer (1965). 1975. PMID: 1220976 No abstract available.
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
Khan AH, Driscoll JS. Khan AH, et al. J Med Chem. 1976 Feb;19(2):313-7. doi: 10.1021/jm00224a022. J Med Chem. 1976. PMID: 1249812
Potential central nervous system antitumor agents. Aziridinylbenzoquinones.
Chou F, Khan AH, Driscoll JS. Chou F, et al. J Med Chem. 1976 Nov;19(11):1302-8. doi: 10.1021/jm00233a010. J Med Chem. 1976. PMID: 1003407
The chemotherapy of human and animal acute leukemia.
Goldin A, Sandberg JS, Henderson ES, Newman JW, Frei E 3rd, Holland JF. Goldin A, et al. Cancer Chemother Rep. 1971 Nov;55(4):309-505. Cancer Chemother Rep. 1971. PMID: 4945857 Review. No abstract available.
The clinical impact of screening and other experimental tumor studies.
Johnson RK, Goldin A. Johnson RK, et al. Cancer Treat Rev. 1975 Mar;2(1):1-31. doi: 10.1016/s0305-7372(75)80013-2. Cancer Treat Rev. 1975. PMID: 1102083 Review. No abstract available.

See all similar articles

Cited by

Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).
Hao D, Rizzo JD, Stringer S, Moore RV, Marty J, Dexter DL, Mangold GL, Camden JB, Von Hoff DD, Weitman SD. Hao D, et al. Invest New Drugs. 2002 Aug;20(3):261-70. doi: 10.1023/a:1016253716438. Invest New Drugs. 2002. PMID: 12201489
Ineffectiveness of inicarone, a fibrinolytic agent, alone or in combination with chemotherapeutic agents on spontaneously metastasizing murine tumours.
Dumont P, Atassi G, De Jager R. Dumont P, et al. Clin Exp Metastasis. 1983 Oct-Dec;1(4):349-57. doi: 10.1007/BF00121197. Clin Exp Metastasis. 1983. PMID: 6546206
New cancer chemotherapy drugs in Europe.
Mathé G, van Putten LM. Mathé G, et al. Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141. Cancer Chemother Pharmacol. 1978. PMID: 373907 Review. No abstract available.
Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans.
Davidse LC, Flach W. Davidse LC, et al. J Cell Biol. 1977 Jan;72(1):174-93. doi: 10.1083/jcb.72.1.174. J Cell Biol. 1977. PMID: 12184 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database